Tenders/Drug with the active substance cerliponase alfa 150 mg, infusion solution

Open🇸🇰SlovakiaSupplies

Drug with the active substance cerliponase alfa 150 mg, infusion solution

Auto-translated from sk

Original title: Liek s účinnou látkou cerliponáza alfa 150 mg, infúzny roztok

Detská fakultná nemocnica s poliklinikou Banská Bystrica

Published: Aug 5, 2026

Updated: Aug 8, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Slovakia, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 2.7 million. Proposals must be submitted before September 10, 2026.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Auto-translated from sk

The subject of the order is a drug with the active substance cerliponase alfa 150 mg, infusion solution. Dosage form: sol inf 5 ml/150 mg+5 ml prepl.roztok (drug.skl.) Administration: intracerebroventricular use. The active substance cerliponase alfa belongs to the group of drugs known as enzyme replacement therapies. It is used to treat patients with neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency. People with CLN2 disease do not have the enzyme called TPP1 or have too little of it, which causes the accumulation of substances called lysosomal storage substances. In people with CLN2 disease, these substances accumulate in certain parts of the body, especially the brain. This drug replaces the missing enzyme called TPPA, thereby minimizing the accumulation of lysosomal storage substances. This drug works by slowing the progression of the disease. The recommended dose is 300 mg of cerliponase alfa, administered once every two weeks by intracerebroventricular infusion.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on August 5, 2026. Last refreshed 1 day ago. Original language: sk. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Detská fakultná nemocnica s poliklinikou Banská Bystrica

Detská fakultná nemocnica s poliklinikou Banská Bystrica has issued 6 procurement notices on BidsFactory, including 1 currently open and 2 awarded contracts. Activity concentrates in Health & Medical. All notices are published for Slovakia. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: August 5, 2026.

Frequently asked questions about this tender

What is the estimated budget?

The estimated contract value is €2,678,665 - €2,678,665. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.

Where will the contract be performed?

The contract is for delivery in Slovakia. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is September 10, 2026. You have 32 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by Detská fakultná nemocnica s poliklinikou Banská Bystrica in Slovakia. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.